Your browser doesn't support javascript.
loading
Creating MHC-Restricted Neoantigens with Covalent Inhibitors That Can Be Targeted by Immune Therapy.
Hattori, Takamitsu; Maso, Lorenzo; Araki, Kiyomi Y; Koide, Akiko; Hayman, James; Akkapeddi, Padma; Bang, Injin; Neel, Benjamin G; Koide, Shohei.
Afiliação
  • Hattori T; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, New York.
  • Maso L; Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, New York.
  • Araki KY; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, New York.
  • Koide A; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, New York.
  • Hayman J; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, New York.
  • Akkapeddi P; Division of Hematology Oncology, Department of Medicine, New York University Grossman School of Medicine, New York, New York.
  • Bang I; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, New York.
  • Neel BG; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, New York.
  • Koide S; Laura and Isaac Perlmutter Cancer Center, New York University Langone Health, New York, New York.
Cancer Discov ; 13(1): 132-145, 2023 01 09.
Article em En | MEDLINE | ID: mdl-36250888

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pulmonares / Complexo Principal de Histocompatibilidade Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pulmonares / Complexo Principal de Histocompatibilidade Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article